Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb;81(2):168-178.
doi: 10.1016/j.jjcc.2022.07.003. Epub 2022 Jul 23.

Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond

Yuichi Saito  1 , Kazuma Oyama  2 , Kenichi Tsujita  3 , Satoshi Yasuda  2 , Yoshio Kobayashi  4
Affiliations
Free article
Review

Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond

Yuichi Saito et al. J Cardiol. 2023 Feb.
Free article

Abstract

Owing to recent advances in early reperfusion strategies, pharmacological therapy, standardized care, and the identification of vulnerable patient subsets, the prognosis of acute myocardial infarction has improved. However, there is still considerable room for improvement. This review article summarizes the latest evidence concerning clinical diagnosis and treatment of acute myocardial infarction.

Keywords: Acute myocardial infarction; Medical therapy; Percutaneous coronary intervention.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Satoshi Yasuda reports honoraria from Daiichi Sankyo Co. Ltd. and Bayer Yakuhin, Ltd., research grants from NEC Solution Innovators, Ltd., Daiichi Sankyo Co. Ltd., Bayer Yakuhin, Ltd. Abbott Medical Japan LLC, Medtronic Japan Co., Ltd., Tesco Co. Ltd., Terumo Co., Nihon Kohden Co, Japan Lifeline Co., Ltd., Sound Wave Innovation CO., LTD., ONO PHARMACEUTICAL CO., LTD., SHIONOGI & CO., LTD., ZEON MEDICAL INC., Nippon Shinyaku Co., Ltd., Nippon Boehringer Ingelheim Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Kowa Company, Ltd., Takeda Pharmaceutical Co. Ltd., Mochida Pharmaceutical Co. Ltd., and BIOTRONIK JAPAN Co. Ltd., and scholarship grants from Abbott Medical Japan LLC, Amicus Therapeutics Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Kowa Company, Ltd., Sumitomo Dainippon Pharma Co., Ltd., and Roche Diagnostics K.K. Other authors report no conflicts of interest to disclose.

LinkOut - more resources